The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Long-term survival of patients receiving multimodality neoadjuvant therapy for resectable or borderline resectable pancreatic ductal adenocarcinoma.
Kinsey McCormick
No relevant relationships to disclose
Samuel H. Whiting
No relevant relationships to disclose
Grace Gyurkey
No relevant relationships to disclose
Wui-Jin Koh
No relevant relationships to disclose
Mika Sinanan
No relevant relationships to disclose
Andrew L. Coveler
No relevant relationships to disclose